Pranav Kansara, MD
Interventional Cardiology · Gainesville, GANPI 1861654881
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by Edwards Lifesciences at 47.4% of the total. 2025 is the largest year on record at $3,368, 2.2 times the $1,542 reported in 2019.
Across 92 payments — averaging $93.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- Abbott$3K
- Medical Device Business Services, Inc.$945
- Siemens Medical Solutions USA, Inc.$154
- Corindus Inc.$149
- Boston Scientific$130
- plus $535 from 14 others
Across 13 payments — averaging $2775.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$36K
What the payments were for
- Travel & lodging$5,00558%
- Food & beverage$3,59242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 30 | $4,078 |
| Abbott | 25 | $2,607 |
| Medical Device Business Services, Inc. | 5 | $945 |
| Siemens Medical Solutions USA, Inc. | 1 | $154 |
| Corindus Inc. | 1 | $149 |
| Boston Scientific | 5 | $130 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $120 |
| Philips North America LLC | 1 | $65 |
| Amgen | 3 | $56 |
| Cardiva Medical, Inc. | 2 | $56 |
| Novo Nordisk | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Inari Medical, Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Biosense Webster, Inc. | 1 | $24 |
| Getinge USA Sales, LLC | 1 | $24 |
| Pfizer | 1 | $21 |
| Livanova USA, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,596 in reported general payments places this provider in the 55th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 156 | $168,431 |
| FarxigaDapagliflozin Propanediol | 89 | $100,323 |
| JardianceEmpagliflozin | 39 | $48,267 |
| XareltoRivaroxaban | 28 | $42,052 |
| EntrestoSacubitril/Valsartan | 31 | $32,203 |
| Repatha SureclickEvolocumab | 13 | $7,184 |
| Metoprolol Succinate | 343 | $6,079 |
| Atorvastatin Calcium | 141 | $2,071 |
| Amlodipine Besylate | 216 | $1,945 |
| Isosorbide Dinitrate | 22 | $1,727 |
| Amiodarone Hcl | 41 | $1,666 |
| Losartan Potassium | 89 | $947 |
| Furosemide | 120 | $792 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 68 | $714 |
| Hydrochlorothiazide | 169 | $658 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $168,431156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Gainesville
- Mudassar AhmedGainesville$193K
- Stephane RinfretGainesville$72K
- Ronnie RamadanGainesville$45K
- Habib SamadyGainesville$42K
- Zachary GeorgeGainesville$24K
- Olga TolevaGainesville$19K
- Marc Allard-RatickGainesville$19K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.